Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 77993Erstellt: 26. Oktober 2026

Eletriptan

Relpax · Relpax free aMine · UK-116044 · ELETRIPTAN · (R)-Eletriptan · Unii-22qoo9B8ki · Eletriptan Free Base · Eletriptan USP/EP/BP

https://huagongshe.com/de/chemical/77993

Molekülstruktur von Eletriptan

Identifikatoren & physikalische Daten

CAS No.143322-58-1
SummenformelC22H26N2O2S
Durchschnittliche Molmasse382,5 g/mol
Monoisotopische Masse382,17149907 g/mol
SMILESCN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12
InChIKeyPWVXXGRKLHYWKM-LJQANCHMSA-N
PubChem CID77993
ChEMBLCHEMBL1510
ChEBICHEBI:50922
EC No.640-088-3
DTXSIDDTXSID9046861

Chemische & physikalische Eigenschaften

XLogP4,1
Polarare Oberfläche (TPSA)61,6
H-Brücken-Donoren1
H-Brücken-Akzeptoren3
Frei drehbare Bindungen6
Schwere Atome27
Formalladung0
Komplexität582
ArzneimittelPharmaceuticals -> Listed in ZINC15
LogP (Verteilungskoeffizient)3.9
LöslichkeitReadily soluble as hydrobromide formulation1.18e-03 g/LDMSO (Slightly), Methanol (Slightly)
Human DrugsBreast FeedingLactationMilk, HumanSerotonin Receptor AgonistsSerotonin 5-HT1 Receptor AgonistsTriptansVasoconstrictor AgentsPharmaceuticals
Physical DescriptionSolid
Collision Cross Section189.45 Ų [M+K]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]186.1 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)]
Schmelzpunkt168-170C
Siedepunkt613.4±55.0 °C(Predicted)
Dichte1.235±0.06 g/cm3(Predicted)
LagerbedingungenSealed in dry,Room Temperature
AggregatzustandSolid
pKa (Säurekonstante)17.14±0.30(Predicted)
FarbePale Yellow to Dark Yellow
StabilitätHygroscopic
InChIInChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1
InChIKeyPWVXXGRKLHYWKM-LJQANCHMSA-N
SMILESN1C2=C(C=C(CCS(C3=CC=CC=C3)(=O)=O)C=C2)C(C[C@H]2CCCN2C)=C1
CAS Datenbank143322-58-1(CAS DataBase Reference)

Sicherheit & Vorschriften

GHS-EinstufungDangerH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P264+P265, P270, P273, P280, P301+P317, P305+P354+P338, P317, P330, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 29 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Unerwünschte WirkungenAdverse events reported from eletriptan use are mostly mild, moderate, and transient. Although eletriptan is associated with nausea, dizziness, drowsiness, and coronary vasoconstriction, the most common adverse effects include a group of sensations referred to as "triptan sensations," including paresthesia, flushing, tingling, chest tightness, and neck pain. Additional effects, such as palpitations, headaches, chills, pain, hypertonia, hypoesthesia, diaphoresis, abdominal pain, including cramps, discomfort, and pressure, xerostomia, dysphagia, dyspepsia, pharyngitis, back pain, and generalized weakness, have been reported, albeit at a much lower incidence ranging from 1% to 7%.
ToxizitätsübersichtSigns and Symptoms of Overdose
Drug Induced Liver InjuryDrug-Induced Liver Injury Severity and Toxicity (DILIst)eletriptanDILI NegativeOralDOI:10.1016/j.drudis.2019.09.022
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
AlarmwortAchtung
GefahrenhinweiseCode Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302

Anwendungen & Verwendung

Verwenden

Eletriptan is a selective serotonin 5-HT1B and 5-HT1D receptor agonist and used to treat migraines (1,2,3).